Bill Illis

Bio:

Bill is all in on innovating the way clinical trials work for the benefit of patients worldwide. For the past several years he has led the Digital Data Flow initiative at the pharmaceutical industry consortium, TransCelerate. Recognizing the foundational nature of clinical trial protocols, this work is centered on removing analog inefficiencies by building transformative industry-wide interoperability through the development and adoption of digital protocol standards in collaboration with CDISC. Focused on sustainable and impactful innovation, Bill has over 25 years of industry experience leading innovative changes in teams, line functions and enterprise programs in Clinical Development (focusing on Operations, Data Mgmt, Programming, Statistics, Data Standards) and R&D Information Technology. Bill is currently Executive Director, Technology & Scientific Computing at Novartis where he is responsible for developing and implementing the analytics technology strategy aimed at improving end-to-end clinical data flows, data science capabilities and clinical trial analysis/reporting processes.